- Home
- CCCC vs ASPI Comparison
CCCC vs ASPI Comparison
Compare CCCC & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- ASPI
- Stock Information
- Founded
- CCCC 2015
- ASPI 2021
- Country
- CCCC United States
- ASPI United States
- Employees
- CCCC N/A
- ASPI N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- CCCC Health Care
- ASPI Industrials
- Exchange
- CCCC Nasdaq
- ASPI Nasdaq
- Market Cap
- CCCC 396.0M
- ASPI 330.8M
- IPO Year
- CCCC 2020
- ASPI 2022
- Fundamental
- Price
- CCCC $3.93
- ASPI $6.17
- Analyst Decision
- CCCC Buy
- ASPI Strong Buy
- Analyst Count
- CCCC 6
- ASPI 2
- Target Price
- CCCC $10.67
- ASPI $4.50
- AVG Volume (30 Days)
- CCCC 2.0M
- ASPI 2.0M
- Earning Date
- CCCC 02-20-2025
- ASPI 11-19-2024
- Dividend Yield
- CCCC N/A
- ASPI N/A
- EPS Growth
- CCCC N/A
- ASPI N/A
- EPS
- CCCC N/A
- ASPI N/A
- Revenue
- CCCC $33,668,000.00
- ASPI $3,383,374.00
- Revenue This Year
- CCCC $75.79
- ASPI $865.76
- Revenue Next Year
- CCCC N/A
- ASPI $700.00
- P/E Ratio
- CCCC N/A
- ASPI N/A
- Revenue Growth
- CCCC 65.45
- ASPI N/A
- 52 Week Low
- CCCC $3.38
- ASPI $1.86
- 52 Week High
- CCCC $11.88
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- CCCC 48.86
- ASPI 60.44
- Support Level
- CCCC $3.79
- ASPI $4.98
- Resistance Level
- CCCC $4.03
- ASPI $5.40
- Average True Range (ATR)
- CCCC 0.26
- ASPI 0.53
- MACD
- CCCC 0.05
- ASPI 0.20
- Stochastic Oscillator
- CCCC 62.50
- ASPI 86.73
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.